Clinical Trial Update: A Prospective, Single-arm, Exploratory Clinical Study of Sintilimab Injection in Combination With Paclitaxel (Albumin-bound) and Gemcitabine in Translational Therapy in Patients With Unresectable Locally Advanced Pancreatic Cancer. [Phase 2]

View source ↗

Summary

Phase 2 exploratory trial evaluating sintilimab with albumin-bound paclitaxel and gemcitabine for unresectable locally advanced pancreatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer
• Unresectable Locally Advanced Pancreatic Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Paclitaxel (albumin-bound) (paclitaxel albumin-bound)
• Sintilimab (sintilimab)

Snippet

Sponsor: RenJi Hospital | Conditions: Unresectable Locally Advanced Pancreatic Cancer | Phase 2 | Status: UNKNOWN